Du Berger R - Search Results

1

Do lupus disease activity measures detect clinically important change?

Fortin PR, Abrahamowicz M, Clarke AE, Neville C, Du Berger R, Fraenkel L, Liang MH. Fortin PR, et al. Among authors: du berger r. J Rheumatol. 2000 Jun;27(6):1421-8. J Rheumatol. 2000. PMID: 10852264 Clinical Trial.

2

The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials.

Abrahamowicz M, Fortin PR, du Berger R, Nayak V, Neville C, Liang MH. Abrahamowicz M, et al. Among authors: du berger r. J Rheumatol. 1998 Feb;25(2):277-84. J Rheumatol. 1998. PMID: 9489819

3

Impact of disease activity and cumulative damage on the health of lupus patients.

Fortin PR, Abrahamowicz M, Neville C, du Berger R, Fraenkel L, Clarke AE, Danoff D. Fortin PR, et al. Among authors: du berger r. Lupus. 1998;7(2):101-7. doi: 10.1191/096120398678919813. Lupus. 1998. PMID: 9541094

4

Adherence during an individualized home based 12-week exercise program in women with fibromyalgia.

Dobkin PL, Da Costa D, Abrahamowicz M, Dritsa M, Du Berger R, Fitzcharles MA, Lowensteyn I. Dobkin PL, et al. Among authors: du berger r. J Rheumatol. 2006 Feb;33(2):333-41. J Rheumatol. 2006. PMID: 16465666 Clinical Trial.

5

The needs of patients with arthritis: the patient's perspective.

Neville C, Fortin PR, Fitzcharles MA, Baron M, Abrahamowitz M, Du Berger R, Esdaile JM. Neville C, et al. Among authors: du berger r. Arthritis Care Res. 1999 Apr;12(2):85-95. doi: 10.1002/1529-0131(199904)12:2<85::aid-art3>3.0.co;2-w. Arthritis Care Res. 1999. PMID: 10513496

6

Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.

Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Côte R, Grover SA, Fortin PR, Clarke AE, Senécal JL. Esdaile JM, et al. Among authors: du berger r. Arthritis Rheum. 2001 Oct;44(10):2331-7. doi: 10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i. Arthritis Rheum. 2001. PMID: 11665973 Free article.

7

Flexible modeling of the effects of serum cholesterol on coronary heart disease mortality.

Abrahamowicz M, du Berger R, Grover SA. Abrahamowicz M, et al. Among authors: du berger r. Am J Epidemiol. 1997 Apr 15;145(8):714-29. doi: 10.1093/aje/145.8.714. Am J Epidemiol. 1997. PMID: 9125998

8

Longitudinal patterns of new Benzodiazepine use in the elderly.

Bartlett G, Abrahamowicz M, Tamblyn R, Grad R, Capek R, du Berger R. Bartlett G, et al. Among authors: du berger r. Pharmacoepidemiol Drug Saf. 2004 Oct;13(10):669-82. doi: 10.1002/pds.908. Pharmacoepidemiol Drug Saf. 2004. PMID: 15386589

9

Modeling cumulative dose and exposure duration provided insights regarding the associations between benzodiazepines and injuries.

Abrahamowicz M, Bartlett G, Tamblyn R, du Berger R. Abrahamowicz M, et al. Among authors: du berger r. J Clin Epidemiol. 2006 Apr;59(4):393-403. doi: 10.1016/j.jclinepi.2005.01.021. J Clin Epidemiol. 2006. PMID: 16549262

10

Flexible modeling of exposure-response relationship between long-term average levels of particulate air pollution and mortality in the American Cancer Society study.

Abrahamowicz M, Schopflocher T, Leffondré K, du Berger R, Krewski D. Abrahamowicz M, et al. Among authors: du berger r. J Toxicol Environ Health A. 2003 Aug 22-Oct 10;66(16-19):1625-54. doi: 10.1080/15287390306426. J Toxicol Environ Health A. 2003. PMID: 12959833

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page